CLINICAL_TRIALS
trial_result
· 2016-03-02
Clinical Trial Update: A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA [NA]
Summary
A prospective study evaluating the specificity of Roche's Cobas TaqScreen MPX test for detecting HBV DNA, HCV RNA, and HIV-1 RNA in plasma pools from source don…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Healthy Volunteer | NA | Status: COMPLETED